Search Results

Fox Chase Cancer Center, Temple Health Delinda Pendleton, BSN, MSN, staff liaison for the Fox Chase Patient and Family Advisory Council, has been named a Planetree Fellow in Person-Centered Care. The fellows program is operated by Planetree International, a leading person-centered care advocacy and standard setting organization. Read More

Last month St. Jude Children’s Research Hospital, 15 of AACI’s leading academic and freestanding cancer center members, all National Cancer Institute (NCI)-Designated Cancer Centers—among them 70 AACI members—and other organizations issued a joint statement urging the nation’s health care systems, physicians, parents, children, and young adults to get human papillomavirus (HPV) vaccinations and other recommended vaccinations back on track. Read More

Case Comprehensive Cancer Center Researchers from the Case Comprehensive Cancer Center, Cleveland Clinic, Case Western Reserve University School of Medicine, and Moffitt Cancer Center have found that the genomic adjusted radiation dose may be used to personalize radiotherapy (RT) to maximize the therapeutic effect of a given physical RT dose. Read More

Rutgers Cancer Institute of New Jersey Researchers from Rutgers Cancer Institute of New Jersey recently discovered a mechanism to explain what drives the formation of mucinous colorectal adenocarcinoma, a rare subtype of colorectal cancer, and has also identified the genes responsible for the regulation of this mechanism. Read More

University of Michigan Rogel Cancer Center A new study led by the University of Michigan Rogel Cancer Center demonstrates how inhibiting a key enzyme known as GOT1 can flip a switch in the cancer cells, causing them to shift from using nutrients to fuel growth toward conserving them to maintain energy levels. Read More

Siteman Cancer Center Geoffrey Hugo, PhD, a Washington University professor of radiation oncology at Siteman Cancer Center, has been named director of the Medical Physics Division in the Department of Radiation Oncology. Dr. Hugo is recognized for his role in developing the use of radioablation to treat patients with cardiac arrhythmias, and for his work advancing adaptive radiotherapy. Read More

The University of Kansas Cancer Center Paul Camarata, MD, neurosurgery clinical service chief at The University of Kansas Health System, has been elected president of the Neurosurgical Society of America. Read More

Duke Cancer Institute, Duke University Medical Center The Duke Cancer Institute Melanoma (and advanced skin cancers) Disease Group has expanded clinic services at its Duke Cancer Center Durham location to include dermatological cancer care for those patients who require multidisciplinary care. Meenal Kheterpal, MD, leads the new clinic. Read More

Roswell Park Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center announces the promotion of Todd Maier, CPA, to vice president of finance. Maier joined Roswell Park in 2014 and has previously served as manager of finance transformation and, more recently, director of financial analytics and planning. Read More

Patient Resource Navigator provides the tools to guide patients through their care continuum. This leading-edge platform offers one-to-one patient education guides and apps, created with specific content for each patient’s diagnosis and treatment plan. System-provided metrics assist in demonstrating patient-centered care, meeting accreditation standards and developing marketplace differentiation. Learn More

Cedars-Sinai Cancer Cedars-Sinai Cancer investigators have found a potential way to block the functioning of a gene mutation that promotes cancer immortality and growth in 70 percent of bladder cancer patients. This discovery may lead to an effective therapy for cancer patients with the mutation, while reducing side effects to normal cells and tissues. Dan Theodorescu, MD, PhD, is director of Cedars-Sinai Cancer and the corresponding author for the study. Read More

University of Virginia Cancer Center University of Virginia Cancer Center has been awarded a Comprehensive Cancer Center designation effective Feb. 1, 2022, by the National Cancer Institute. The application for the designation required submission of a 1,300-page application, followed by a site visit from 14 distinguished scientists and physicians. Thomas P. Loughran, Jr., MD, is director of the center. Read More

Vanderbilt-Ingram Cancer Center President Joseph Biden has appointed Karen Winkfield, MD, PhD, to the 18-member National Cancer Advisory Board, where she will serve a six-year term helping to guide federal initiatives that focus on cancer. Read More

University of New Mexico Comprehensive Cancer Center The University of New Mexico Comprehensive Cancer Center has again been awarded the highest designation and rating in the United States for cancer treatment and research programs by the National Cancer Institute. Its initial designation came in 2005 with renewals in 2010 and 2015. Alan E. Tomkinson, PhD, is the center's interim director. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Baylor College of Medicine and Stanford University received an award for more than $25 million over five years from the National Institutes of Health to continue building the Clinical Genome (ClinGen) Resource, an effort to create expert curated knowledge about clinically relevant genes and genomic variants for use in precision medicine. The award is one of three NIH grants totaling $73.2 million over five years for t…

Case Comprehensive Cancer Center The Case Comprehensive Cancer Center has earned an additional $12 million from the National Cancer Institute as a two-year merit-based extension of its Cancer Center Support Grant. The center is the first of two NCI-Designated Comprehensive Cancer Centers to be awarded this distinction. Stan Gerson, MD, is the center's director. Read More

Duke Cancer Institute, Duke University Medical Center Duke University is the recipient of two large grants totaling nearly $12 million from the National Human Genome Research Institute as part of its new Impact of Genomic Variation on Function Consortium. The consortium will bring investigators together in a highly collaborative effort to examine how genomes function, how genome function shapes phenotypes, and how these processes are influenced by genomic variation. Read More

Stanford Cancer Institute Crystal Mackall, MD, director of the Stanford Center for Cancer Cell Therapy, was awarded nearly $12 million to investigate whether CAR T cell therapy can be modified to target a brain and spinal cord cancer called diffuse midline glioma. Read More

UCSF Helen Diller Family Comprehensive Cancer Center Under the leadership of Ana Velázquez Mañana, MD, fellow in medical oncology, UCSF, was chosen as one of only five institutions nationwide to participate in the American Society of Clinical Oncology's (ASCO) inaugural Oncology Summer Internship program to increase diversity in the oncology workforce. Read More

Roswell Park Comprehensive Cancer Center Teams of researchers from Roswell Park Comprehensive Cancer Center and the University of Chicago Medicine Comprehensive Cancer Center are combining efforts after together securing a nearly $9 million grant from the National Cancer Institute to develop new and better treatments for ovarian cancer. Read More

The University of Kansas Cancer Center National Cancer Institute Director Ned Sharpless, MD, and Office of Cancer Centers Director Henry Ciolino, PhD, joined Roy Jensen, MD, director of The University of Kansas Cancer Center, for a special episode of the center’s Facebook Live series "Bench to Bedside" on September 29 to discuss the 50th anniversary commemoration of the National Cancer Act, as well as the latest in cancer research, the impact of the COVID-19 pandemic on cancer research, …

VCU Massey Comprehensive Cancer Center Virginia Commonwealth University Massey Cancer Center has won a SPORE grant intended to move research findings quickly from the laboratory to patients to address the disproportionate effects of lung cancer on the Black community. The SPORE funding will establish the Translational Research Center in Lung Cancer Disparities. Principal investigator is VCU Massey Director Robert Winn, MD. Read More

University of Illinois Cancer Center University of Illinois Cancer Center researchers have discovered a potential drug target for treating aggressive pancreatic cancer. Their findings showed that an experimental compound inhibited pancreatic cancer in mice, significantly extending their survival and reducing tumor growth in a mouse model of pancreatic ductal adenocarcinoma. Read More

The University of Kansas Cancer Center The University of Kansas Cancer Center was invited to participate in a national pilot project being conducted by the American Society of Clinical Oncology and the Association of Community Cancer Centers. The pilot project is testing a research site self-assessment tool and an implicit bias training program focused on increasing racial and ethnic diversity among cancer treatment trial participants. Read More

The University of Texas MD Anderson Cancer Center A new discovery from researchers at The University of Texas MD Anderson Cancer Center has clarified the long-established connection between inflammation and pancreatic cancer development. According to the study, pancreatic cells display an adaptive response to repeated inflammatory episodes that initially protects against tissue damage but can promote tumor formation in the presence of mutant KRAS. Read More

Huntsman Cancer Institute at the University of Utah Cells have quality controls, or checkpoints, to keep mistakes from happening. One of the last steps in cell division is a quality control process called the abscission checkpoint. If that checkpoint doesn’t work, cells divide even with mistakes present. This contributes to a higher risk of several kinds of cancer. Collaborative research from labs at Huntsman Cancer Institute looks at how the abscission checkpoint functions. Rea…

Rutgers Cancer Institute of New Jersey Carolyn Hayes, PhD, RN, NEA-BC, chief nursing officer for Oncology Services at RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, has been selected by the American Academy of Nursing as a 2021 Fellow. Read More

Siteman Cancer Center Blood and urine tests could lead to faster and less invasive methods to diagnose and monitor various types of tumors, according to new research from Washington University scientists at Siteman Cancer Center. Two studies describe the potential of liquid biopsies to identify and track tumor growth in bladder cancer and peripheral nerve tumors. Read More

UMMC Cancer Center and Research Institute Kelly Brister, MD, a colorectal surgeon, has joined the University of Mississippi Medical Center Interdisciplinary Gastrointestinal Cancer Team. She will provide care to a population with one of the lowest colorectal cancer screening rates in the nation. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center John Turchi, PhD, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, received a five-year, $2.5 million grant from the National Cancer Institute to develop a novel therapy to treat lung cancer. Read More

Wilmot Cancer Institute, UR Medicine Popular Science magazine has named Michael Giacomelli, PhD, a member of the Wilmot Cancer Institute, to its "Brilliant 10" list for 2021. The early-career biomedical engineer, who invented a novel imaging device, joins the magazine’s lineup of the most innovative and creative minds of the year. Read More

University of Michigan Rogel Cancer Center President Joseph Biden named Christopher Friese, PhD, RN, among seven new members of the National Cancer Advisory Board. Dr. Friese is associate director for cancer control and population sciences at the University of Michigan Health Rogel Cancer Center. He is a national expert in the analyses of claims data to study care quality and has executed large surveys of ambulatory oncology nurses. Read More

UCLA Jonsson Comprehensive Cancer Center Alice Soragni, PhD, has received a $2.5 million grant from the National Cancer Institute to develop lab-grown mini tumors that can help identify treatments for rare types of neuroendocrine cancer. The grant is a joint partnership with Patricia Dahia, MD, PhD, of the University of Texas Health Science Center at San Antonio. Read More

The University of Arizona Cancer Center An enzyme with an elusive role in severe inflammation may be a key mechanism driving COVID-19 severity and could provide a new therapeutic target to reduce COVID-19 mortality, according to a study by researchers from the University of Arizona, in collaboration with Stony Brook University and Wake Forest School of Medicine. Read More

Fred Hutchinson Cancer Center A new study by Joseph Unger, PhD, MS, of Fred Hutchinson Cancer Research Center, showed there was little evidence of enrollment reductions to treatment trials during the entire first year of the pandemic. Rather, it’s the eligibility criteria that keeps most cancer patients out of trials. Read More

Sidney Kimmel Cancer Center at Jefferson Health Tebentafusp, an investigational bispecific fusion protein, significantly improves overall survival among patients with metastatic uveal melanoma, according to results from a multicenter, randomized, Phase III clinical trial. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors’ genes and proteins. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute A study at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute turns cancer scientists into molecular detectives, searching for clues for why certain cancers are able to spread and evolve by studying tissues collected within hours of death. The Rapid Cancer Research Autopsy Trial allows scientists to gather biological samples …

Fred Hutchinson Cancer Center A new computational method called CoNGA could help bring into focus the hidden biological patterns that link T-cell receptor, or TCR, gene sequences and T-cell function. Read More

Ellen and Ronald Caplan Cancer Center of The Wistar Institute The Wistar Institute announces the appointment of Italo Tempera, PhD, as associate director for cancer research career enhancement at the institute’s cancer center. In this role, Dr. Tempera will lead the educational mission of the institute and its cancer center to train scientists and create workforce development programs in the life sciences. Read More

VCU Massey Comprehensive Cancer Center For the last 17 years, Emmanuel A. Taylor, MSc, DrPH, served as health scientist administrator and program director in the Office of the Director of the Center to Reduce Cancer Health Disparities at the National Cancer Institute. He now joins Virginia Commonwealth University as a researcher at Massey Cancer Center. Read More

Wilmot Cancer Institute, UR Medicine Individuals diagnosed with intrahepatic cholangiocarcinoma, a type of liver cancer, face a five-year survival rate of less than 10 percent. But a Wilmot Cancer Institute team that also investigates pancreatic cancer, which has similarly poor survival statistics, discovered factors that both aggressive cancers have in common. Read More

UK Markey Cancer Center A new study from UK Markey Cancer Center researchers demonstrate a combination of two drugs may be useful to treat ovarian cancers that are resistant to paclitaxel. Read More

USC Norris Comprehensive Cancer Center New research reveals children born with a genetic predisposition to produce more lymphocytes, particularly in relation to other types of white blood cells, are at a higher risk of developing acute lymphoblastic leukemia. Read More

The University of Arizona Cancer Center The University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors. Read More

Cedars-Sinai Cancer Cedars-Sinai Cancer researchers have created a new system for classifying melanoma when the disease has spread to the lymph nodes. This system may offer a better tool for predicting patients' outcomes and determining their treatment needs. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UCSF researchers discover a new role for Erα as an RNA-binding protein, offering clues to overcoming resistance to therapies like tamoxifen that are used in many types of breast cancer. Read More

Robert H. Lurie Comprehensive Cancer Center of Northwestern University Neurosurgical oncologist, Amy Heimberger, MD, has joined the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as the Jean Malnati Miller Professor of Brain Tumor Research and scientific director of the Lou and Jean Malnati Brain Tumor Institute of the Lurie Cancer Center. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indiana University School of Medicine has named its first executive director of the Brown Center for Immunotherapy. Huda Salman, MD, PhD, will become the center’s new leader, effective November 1. She joins IU School of Medicine from Stony Brook Cancer Center, where she directs the CAR T-cell program. Read More

Duke Cancer Institute, Duke University Medical Center The German National Academy of Sciences Leopoldina has elected Joseph Heitman, MD, PhD, chair of the Department of Molecular Genetics and Microbiology at Duke University School of Medicine, and member of Duke Cancer Institute, as one of its members. Read More

Ellen and Ronald Caplan Cancer Center of The Wistar Institute The Wistar Institute welcomes Amelia Escolano, PhD, and Nan Zhang, PhD, as assistant professors. Dr. Escolano’s research focuses on the development of novel vaccine approaches against highly mutating viruses. Dr. Zhang studies the role of a group of white blood cells known as macrophages during ovarian cancer metastasis in the abdominal cavity. Read More

Masonic Cancer Center, University of Minnesota Aaron Schilz, MPA, has been appointed as the interim executive director for the Masonic Cancer Center. He assumes the position previously held by Seanne Falconer, MBA, FACHE, who has accepted the role of executive director, administration at the Moores Cancer Center at UC San Diego Health. Read More

Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey and RWJBarnabas Health welcome Missak Haigentz, Jr., MD, as chief of Thoracic and Head and Neck Medical Oncology and clinical director for Oncology Integration. Read More

University of Illinois Cancer Center Yamilé Molina, PhD, MPH, MS, has been named associate director for community outreach and engagement for the University of Illinois Cancer Center. She takes the helm from Karriem Watson, DHSc, MS, MPH, as he transitions to a new leadership role as chief engagement officer for the All of Us research initiative at the National Institutes of Health. Read More

Roswell Park Comprehensive Cancer Center Carl Morrison, MD, DVM, has been promoted to chair of pathology and laboratory medicine. Dr. Morrison, who joined Roswell Park in 2007, remains senior vice president for scientific development and integrative medicine. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute predoctoral fellow Prasoona Karra, MS, was selected to receive the National Cancer Institute (NCI) Predoctoral to Postdoctoral Fellow Transition Award. These awards are presented to “outstanding predoctoral researchers” and are designed to support them in the late stages of PhD training through transition to postdoctoral position. The award provides up to six years of funding. Read More

The University of Texas MD Anderson Cancer Center A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Read More

University of Michigan Rogel Cancer Center Communication between patients and their primary care providers is key to ensuring effective cancer care, both before diagnosis and after treatment, according to two recent papers led by University of Michigan Rogel Cancer Center researchers. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University In human cancer cell and mouse studies, researchers from Johns Hopkins Medicine have found that a set of proteins work in tandem to build supply lines that deliver oxygen and nutrients to tumors, enabling them to survive and grow. Read More

Case Comprehensive Cancer Center Researchers from the Case Comprehensive Cancer Center have uncovered the potentially important role of the protein-coding gene, MYO10, in tumor development and immune therapy response. Read More

Masonic Cancer Center, University of Minnesota Emmanuel S. Antonarakis, MD, has joined the University of Minnesota Medical School faculty as associate director for translational research at Masonic Cancer Center. He succeeds Jill Siegfried, PhD. Dr. Antonarakis will also serve as director of genitourinary oncology in the Department of Medicine’s Division of Hematology, Oncology, and Transplantation of the U of M Medical School. Read More

Vanderbilt-Ingram Cancer Center The Meharry Medical College/Vanderbilt-Ingram Cancer Center/Tennessee State University Partnership (MVTCP) has received renewed funding for the next five years to continue collaborations to eliminate cancer health disparities. Entering its 22nd consecutive year of funding, the MVTCP is the longest-standing partnership supported through the National Cancer Institute's U54 Comprehensive Partnerships to Advance Cancer Health Equity program. Read More

Siteman Cancer Center Brian C. Baumann, MD, a radiation oncologist at Siteman Cancer Center, has been awarded a 2021 Cancer Clinical Investigator Team Leadership Award from the National Cancer Institute. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center and the Marvin and Concetta Greenberg Pancreatic Cancer Institute were recently renewed as a Clinical Center of Excellence and named for the first time as an Academic Center of Excellence for Pancreatic Cancer by the National Pancreas Foundation. Read More

Sidney Kimmel Cancer Center at Jefferson Health Video-based education is an acceptable pretesting alternative to traditional consultations with a genetic counselor for many men with prostate cancer or at-risk for prostate cancer who have been referred for genetic testing, according to results from the Evaluation and Management for Prostate Oncology, Wellness, and Risk study from researchers at the Sidney Kimmel Cancer Center at Jefferson Health. Read More

Stanford Cancer Institute In a recent study, a team of Stanford researchers identified hundreds of potential targets for cancer therapies using a new screening strategy that allows for the systematic activation and deactivation of thousands of genes in both cancer cells and immune cells. Read More

UMMC Cancer Center and Research Institute Carolann Risley, PhD, MSN, recently returned to the University of Mississippi Medical Center as an associate professor of nursing and member of the UMMC Cancer Center and Research Institute. She has focused on research into the basis for racial disparities in cervical cancer since she was a UMMC graduate student. Read More

UAMS Winthrop P. Rockefeller Cancer Institute The Association of American Medical Colleges (AAMC) recently bestowed the Spencer Foreman Award for Outstanding Community Engagement on the University of Arkansas for Medical Sciences (UAMS). The award is presented annually to an AAMC-member medical school or teaching hospital with a long-standing, major institutional commitment to partnering with the community it serves. Read More

The 2021 AACI/CCAF Annual Meeting will virtually convene AACI cancer center members with national cancer research and advocacy groups, industry, and government health agencies on October 19-21. In honor of the 50th anniversary of the National Cancer Act (NCA), one meeting session will examine the last 50 years of progress and potential for the future. Read More

This fall, AACI will welcome new members to its Clinical Research Innovation (CRI) Steering Committee. The new members will formally assume their duties during the 2021 AACI/CCAF Annual Meeting, held virtually October 19-21. AACI is also seeking nominations for new members to join the Physician Clinical Research (PCLI) Steering Committee. Read More

AACI recently launched a listserv for community outreach and engagement professionals at AACI cancer centers. The purpose of the listserv is to provide a platform for members to ask questions or reach out to others about COE-related topics. Read More

"These guides build bi-directional communication between our providers and their patients. We’ve seen an increase in patient retention and overall patient satisfaction." - Terry T. Tsue, MD, FACS, Vice President and Physician-in-Chief, The University of Kansas Cancer Center; Vice President of Physician Services, The University of Kansas Health System For more information, please contact Amy Galey. Learn More

Last month, AACI partnered with Mediaplanet on its Transforming Cancer Care campaign, highlighting the ways in which the health care community is advancing equitable cancer care through innovation and global collaboration. AACI cancer centers and sustaining members are among those featured in this special supplement to the September 23 issue of USA TODAY, which also includes a full-page ad from AACI. Read More

Hollings Cancer Center, Medical University of South Carolina U.S. First Lady Jill Biden visited MUSC Hollings Cancer Center on October 25. In attendance were MUSC President David J. Cole, MD, FACS; Hollings Director Raymond N. DuBois, MD, PhD; Marvella E. Ford, PhD, Hollings associate director of population sciences and cancer disparities; and Norman E. Sharpless, MD, director of the National Cancer Institute. Read More

UCSF Helen Diller Family Comprehensive Cancer Center Funded by a five-year, $22.5 million grant from the National Institute on Minority Health and Health Disparities, UC San Francisco faculty will coordinate research from 11 newly funded centers across the U.S. on the root causes of, and ways to eliminate, disparities in multiple chronic diseases. Read More

USC Norris Comprehensive Cancer Center President Joe Biden has appointed John Carpten, PhD, to serve as chair of the administration’s National Cancer Advisory Board. Dr. Carpten is the founding chair of translational genomics at the Keck School of Medicine of USC, founding director of the USC Institute of Translational Genomics, and associate director of basic sciences for the USC Norris Comprehensive Cancer Center. Read More

After an extensive national search, Yale School of Medicine and Yale New Haven Health have announced that Eric P. Winer, MD, will be the next director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital at Yale New Haven, effective February 1, 2022. Dr. Winer is currently vice president for medical affairs at Dana-Farber Cancer Institute. Read More

AACI welcomes the Hematology/Oncology Pharmacist Association (HOPA) to its roster of sustaining members. Founded in 2004, HOPA is a professional society for hematology/oncology pharmacists and associates. The organization’s mission is to support these pharmacy practitioners and optimize the care of individuals affected by cancer. HOPA also promotes the importance of oncology pharmacists to the cancer care team. Read More

Wilmot Cancer Institute, UR Medicine To find people who are behind on cancer screenings and then motivate them to follow through, an innovative team is leveraging the emergency department at UR Medicine sites. The study looks at whether a text message reminder is more effective than a standard referral for prompting screenings. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has named Antwione Haywood, PhD, its associate director of diversity, equity, and inclusion (DEI). Dr. Haywood is the first person to hold the chief diversity officer position at the cancer center. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Kathy Miller, MD, and Ken Nephew, PhD, are among nearly 20 scientists at six institutions who will work to improve epigenetic therapies for cancer with a five-year, estimated $12.4 million Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute. Read More

UK Markey Cancer Center A new study from the lab of UK Markey Cancer Center Director Mark Evers, MD, demonstrates the critical role of the hormone neurotensin in cell proliferation and stem cell function in the small intestine. Read More

Siteman Cancer Center Washington University researchers at Siteman Cancer Center are joining the National Institutes of Health’s new research network focused on the study of senescent cells, a rare and important population of cells that is difficult to study but vital for understanding aging and diseases of aging, including cancer and neurodegeneration. Li Ding, PhD, is principal investigator. Read More

University of Virginia Cancer Center University of Virginia (UVA) Cancer Center is participating in a pilot project that seeks to increase racial and ethnic diversity among cancer treatment trial volunteers. The initiative is led by the American Society of Clinical Oncology and the Association of Community Cancer Centers. Read More

VCU Massey Comprehensive Cancer Center VCU Massey Cancer Center is now using an FDA-approved substance called Magtrace that allows surgeons to spare the lymph nodes in the vast majority of early-stage breast cancer patients, reducing their risk of developing lymphedema months or years later. Read More

Montefiore Einstein Comprehensive Cancer Center Ulrich G. Steidl, MD, PhD, associate director of basic science at the Albert Einstein Cancer Center, has received a a seven-year, $7 million Outstanding Investigator Award from the National Cancer Institute to study the molecular and cellular mechanisms that lead to myelodysplastic syndromes and acute myeloid leukemia. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Helen Heslop, MD, DSc (Hon), director of the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital and interim director of the Dan L Duncan Comprehensive Cancer Center at Baylor, has been elected to the National Academy of Medicine. Read More

Wilmot Cancer Institute, UR Medicine Wilmot Cancer Institute data establish for the first time that "chemo brain" is a major problem for lymphoma survivors. The research is relevant due to a rising number of cancer survivors. Given those strides, it’s important to address the consequences of treatment, said Jonathan Friedberg, MD, MMSc, Wilmot’s director and an international lymphoma expert. Read More

University of Michigan Rogel Cancer Center Cancer centers and/or health care systems that prioritize coordination and communication provide higher-quality end-of-life care for cancer patients who are eligible for both Medicare and Medicaid, University of Michigan researchers found. Read More

USC Norris Comprehensive Cancer Center Chanita Hughes-Halbert, PhD, associate director for cancer equity at USC Norris Comprehensive Cancer Center, will collaborate with Robert Winn, MD, director of VCU Massey Cancer Center, and scientific leaders at MUSC Hollings Cancer Center and City of Hope Comprehensive Cancer Center to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs, and community outreach. Read More

Vanderbilt-Ingram Cancer Center Cathy Eng, MD, has been elected co-chair of the National Cancer Institute Gastrointestinal Cancer Steering Committee, which is responsible for supervising clinical trials. Trials overseen by the committee include neuroendocrine tumors, gastroesophageal carcinoma, rectal-anal and colon cancers, hepatocellular tumors, and pancreatic cancer. Read More

University of New Mexico Comprehensive Cancer Center UNM Comprehensive Cancer Center researchers, led by Cosette Wheeler, PhD, have found that many women are screened for cervical cancer too often, leading to unnecessary procedures that may carry their own harms, while some women are not getting tested often enough. Read More

Stanford Cancer Institute Recent research by Wendy Fantl, PhD, and Veronica Gonzalez, PhD, shows that ovarian tumors thrive by convincing nearby immune cells that the cancer cells are those of a developing fetus. They do so by transferring a molecule called CD9 from their cell surface to the surface of the immune cells via trogocytosis. Read More

The University of Kansas Cancer Center The International Society of Gastrointestinal Oncology, a nonprofit global educational organization committed to gastrointestinal oncology, recently named Weijing Sun, MD, as its new president. Dr. Sun is associate director of clinical research at The University of Kansas Cancer Center. Read More

Fred Hutchinson Cancer Center A team of research experts from the COVID-19 Prevention Network, or CoVPN, headquartered at Fred Hutchinson Cancer Research Center, have demonstrated that through robust community engagement, equitable inclusion in vaccine clinical trials can make a powerful impact in the health of underrepresented communities. Read More

UMMC Cancer Center and Research Institute Paula Domino, MD, a urologic surgeon specializing in restoring function for patients with urinary and pelvic challenges, has joined the University of Mississippi Medical Center from Memorial Sloan Kettering Cancer Center, where she completed a fellowship in voiding dysfunction and pelvic reconstruction. Read More

UCSF Helen Diller Family Comprehensive Cancer Center In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, a team of researchers led by investigator Joel Palefsky, MD, found that by removing high-grade squamous intraepithelial lesions, chances of progression to anal cancer were significantly reduced. Read More